We are monitoring the impact of COVID-19 on Europe Contraceptives Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1156
Share on
Share on

Europe Contraceptives Market Research Report – Segmented By Drug Type, Medical Devices, End-Users, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2020 to 2025

Pulished: February, 2020
ID: 1156
Pages: 136

Europe Contraceptives Market Size (2020 to 2025)

As per our report, the size of the Europe Contraceptives Market was worth USD 6.35 billion in 2020 and estimated to reach USD 8.7 billion by the end of 2025 with a growing potential of 6.50 %.

The European contraceptives market enjoys a high degree of product penetration, especially in segments such as subdermal implants and intrauterine devices (IUD).

Male and female condoms, vaginal implants, subdermal implants, sponges, IUDs, and diaphragms are essential devices and accounted for the largest share of the market in terms of revenue. It is attributed to growing awareness about STD (Sexually transmitted disease) and the efficiency of condoms to inhibit the infections, including HIV. In a recent study, subdermal implants have been recognized to have an immense potential to meet the need of women for family planning.

Major factors that are driving the European contraceptives market are increasing the development of active female contraceptive devices and drugs, advancement in technologies, increasing initiatives from government, and NGO to promote contraceptives.

Restraints the growth of the market are the side effects associated with the use of contraceptive devices and drugs, rising prevalence of infertility.

This research report has been segmented & sub-segmented into the following categories:

  • By Drug Type: Contraceptive Pills, Topical Contraceptives, Contraceptive Injectable & Others (Contraceptive Gels, Jellies, and Creams)
  • By Medical Devices: Male Contraceptive Devices (Condoms), Female Contraceptive Devices (Female Condoms, Intrauterine Devices (Hormonal IUD’s, Copper IUD’s)), Contraceptive Sponges, Contraceptive Diaphragms, Subdermal Contraceptive Implants, Contraceptive Patches, Non-Surgical Permanent Contraceptive Devices
  • By End User: Hospitals, Home Care, Clinics & Ambulatory Surgical Centres
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Key market participants leading the Europe contraceptives market are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Drug type                              

                                5.1.1 Contraceptive pills               

                                5.1.2 Topical contraceptives       

                                5.1.3 Contraceptive injectable   

                                5.1.4 Others (contraceptive gels, jellies and creams)        

                5.2 By Medical Devices                 

                                5.2.1 Male contraceptive devices             

                                5.2.2 Female contraceptive devices        

                                                5.2.2.1 Female condoms

                                                5.2.2.2 Intrauterine devices

                                               

                                               

                                                5.2.2.3 Contraceptive sponges

                                                5.2.2.4 Contraceptive diaphragms

                                                5.2.2.5 Contraceptive patches

                                                5.2.2.6 Subdermal contraceptive implants

                                                5.2.2.7 Non-surgical permanent contraceptive devices

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 U.K

                                6.3 Spain             

                                6.4 Germany     

                                6.5 Italy               

                                6.6 France          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bayer HealthCare AG                             

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Teva Pharmaceutical Industries Limited                         

                8.3 Medisafe Distribution Inc                     

                8.4 Pace Pharmaceuticals Inc                     

                8.5 Medicines360                            

                8.6 Church & Dwight, Co., Inc.                   

                8.7 Actavis, Inc                 

                8.8 CooperSurgical                         

                8.9 Merck & Co., Inc                       

                8.10 Reckitt Benckiser plc                            

                8.11 Mayer Laboratories, Inc                      

                8.12 Pfizer, Inc                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Market outlook and Investment oppurtunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe Contraceptives Market By Drug type, From 2020 to 2025 (USD Billion)
  2. Europe Contraceptive pills Market By Region, From 2020 to 2025 (USD Billion)
  3. Europe Topical contraceptives Market By Region, From 2020 to 2025 (USD Billion)
  4. Europe Contraceptive injectable Market By Region, From 2020 to 2025 (USD Billion)
  5. Europe Contraceptives Market By Medical Devices, From 2020 to 2025 (USD Billion)
  6. Europe Male Contraceptive devices Market By Region, From 2020 to 2025 (USD Billion)
  7. Europe Female Contraceptive devices Market By Region, From 2020 to 2025 (USD Billion)
  8. Europe Contraceptives Market By End users, From 2020 to 2025 (USD Billion)
  9. Europe Hospitals Market By Region, From 2020 to 2025 (USD Billion)
  10. Europe Home care Market By Region, From 2020 to 2025 (USD Billion)
  11. Europe Clinics Market By Region, From 2020 to 2025 (USD Billion)
  12. Europe Ambulatory Surgical Centres Market By Region, From 2020 to 2025 (USD Billion)
  13. U.K. Contraceptives Market By Drug type, From 2020 to 2025 (USD Billion)
  14. U.K. Contraceptives Market By Medical Devices, From 2020 to 2025 (USD Billion)
  15. U.K. Contraceptives Market By End users, From 2020 to 2025 (USD Billion)
  16. Germany Contraceptives Market By Drug type, From 2020 to 2025 (USD Billion)
  17. Germany Contraceptives Market By Medical Devices, From 2020 to 2025 (USD Billion)
  18. Germany Contraceptives Market By End users, From 2020 to 2025 (USD Billion)
  19. France Contraceptives Market By Drug type, From 2020 to 2025 (USD Billion)
  20. France Contraceptives Market By Medical Devices, From 2020 to 2025 (USD Billion)
  21. France Contraceptives Market By End users, From 2020 to 2025 (USD Billion)
  22. Italy Contraceptives Market By Drug type, From 2020 to 2025 (USD Billion)
  23. Italy Contraceptives Market By Medical Devices, From 2020 to 2025 (USD Billion)
  24. Italy Contraceptives Market By End users, From 2020 to 2025 (USD Billion)
  25. Spain Contraceptives Market By Drug type, From 2020 to 2025 (USD Billion)
  26. Spain Contraceptives Market By Medical Devices, From 2020 to 2025 (USD Billion)
  27. Spain Contraceptives Market By End users, From 2020 to 2025 (USD Billion)
  28. Europe Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  29. Europe female condoms Market By Region, From 2020 to 2025 (USD Billion)
  30. Europe intrauterine devices Market By Region, From 2020 to 2025 (USD Billion)
  31. Europe contraceptive sponges Market By Region, From 2020 to 2025 (USD Billion)
  32. Europe contraceptive diaphragms Market By Region, From 2020 to 2025 (USD Billion)
  33. Europe contraceptive patches Market By Region, From 2020 to 2025 (USD Billion)
  34. Europe subdermal contraceptive implants Market By Region, From 2020 to 2025 (USD Billion)
  35. Europe non-surgical permanent contraceptive devices Market By Region, From 2020 to 2025 (USD Billion)
  36. U.K. Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  37. Germany Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  38. France Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  39. Italy Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  40. Spain Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  41. Europe Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  42. Europe female condoms Market By Region, From 2020 to 2025 (USD Billion)
  43. Europe intrauterine devices Market By Region, From 2020 to 2025 (USD Billion)
  44. Europe contraceptive sponges Market By Region, From 2020 to 2025 (USD Billion)
  45. Europe contraceptive diaphragms Market By Region, From 2020 to 2025 (USD Billion)
  46. Europe contraceptive patches Market By Region, From 2020 to 2025 (USD Billion)
  47. Europe subdermal contraceptive implants Market By Region, From 2020 to 2025 (USD Billion)
  48. Europe non-surgical permanent contraceptive devices Market By Region, From 2020 to 2025 (USD Billion)
  49. U.K. Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  50. Germany Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  51. France Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  52. Italy Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  53. Spain Contraceptives Market, By Female contraceptive Devices, From 2020 to 2025 (USD Billion)
  54. Europe Contraceptives Market, By Intrauterine devices, From 2020 to 2025 (USD Billion)
  55. Europe Hormonal IUD's Market By Region, From 2020 to 2025 (USD Billion)
  56. U.K. Contraceptives Market, By Intrauterine devices, From 2020 to 2025 (USD Billion)
  57. Germany Contraceptives Market, By Intrauterine devices, From 2020 to 2025 (USD Billion)
  58. France Contraceptives Market, By Intrauterine devices, From 2020 to 2025 (USD Billion)
  59. Italy Contraceptives Market, By Intrauterine devices, From 2020 to 2025 (USD Billion)
  60. Spain Contraceptives Market, By Intrauterine devices, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample